{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:34:30Z","timestamp":1791952470336,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The dysfunction of OPA1, a dynamin GTPase involved in mitochondrial fusion, is responsible for a large spectrum of neurological disorders, each of which includes optic neuropathy. The database dedicated to OPA1 (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.lovd.nl\/OPA1\">\n                      <jats:italic>https:\/\/www.lovd.nl\/OPA1<\/jats:italic>\n                    <\/jats:ext-link>), created in 2005<jats:italic>,<\/jats:italic> has now evolved towards a centralized and more reliable database using the Global Variome shared Leiden Open-source Variation Database (LOVD) installation.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The updated <jats:italic>OPA1<\/jats:italic> database, which registers all the patients from our center as well as those reported in the literature, now covers a total of 831 patients: 697 with isolated dominant optic atrophy (DOA), 47 with DOA \u201cplus\u201d, and 83 with asymptomatic or unclassified DOA. It comprises 516 unique <jats:italic>OPA1<\/jats:italic> variants, of which more than 80% (414) are considered pathogenic. Full clinical data for 118 patients are documented using the Human Phenotype Ontology, a standard vocabulary for referencing phenotypic abnormalities. Contributors may now make online submissions of phenotypes related to <jats:italic>OPA1<\/jats:italic> mutations, giving clinical and molecular descriptions together with detailed ophthalmological and neurological data, according to an international thesaurus.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The evolution of the <jats:italic>OPA1<\/jats:italic> database towards the LOVD, using unified nomenclature, should ensure its interoperability with other databases and prove useful for molecular diagnoses based on gene-panel sequencing, large-scale mutation statistics, and genotype-phenotype correlations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-019-1187-1","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T05:22:16Z","timestamp":1568092936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database"],"prefix":"10.1186","volume":"14","author":[{"given":"Bastien","family":"Le Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lenaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Zanlonghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Amati-Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris","family":"Chabrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Foulonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lique","family":"Caignard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Leruez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gohier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Procaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Milea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan T.","family":"den Dunnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Reynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8265-7249","authenticated-orcid":false,"given":"Marc","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"issue":"Supp 54","key":"1187_CR1","first-page":"1","volume":"164","author":"P Kjer","year":"1959","unstructured":"Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol. 1959;164(Supp 54):1\u2013147.","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"1187_CR2","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.ophtha.2009.12.038","volume":"117","author":"P Yu-Wai-Man","year":"2010","unstructured":"Yu-Wai-Man P, Griffiths PG, Burke A, Sellar PW, Clarke MP, Gnanaraj L, et al. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology. 2010;117(8):1538\u201346 46 e1.","journal-title":"Ophthalmology"},{"issue":"6","key":"1187_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/hmg\/3.6.977","volume":"3","author":"H Eiberg","year":"1994","unstructured":"Eiberg H, Kjer B, Kjer P, Rosenberg T. Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis. Hum Mol Genet. 1994;3(6):977\u201380.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1187_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1600-0420.1996.tb00672.x","volume":"74","author":"B Kjer","year":"1996","unstructured":"Kjer B, Eiberg H, Kjer P, Rosenberg T. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand. 1996;74(1):3\u20137.","journal-title":"Acta Ophthalmol Scand"},{"key":"1187_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1750-1172-7-46","volume":"7","author":"G Lenaers","year":"2012","unstructured":"Lenaers G, Hamel C, Delettre C, Amati-Bonneau P, Procaccio V, Bonneau D, et al. Dominant optic atrophy. Orphanet J Rare Dis. 2012;7:46.","journal-title":"Orphanet J Rare Dis"},{"key":"1187_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nbd.2015.08.015","volume":"90","author":"C de la Barca JM","year":"2016","unstructured":"de la Barca JM C, Prunier-Mirebeau D, Amati-Bonneau P, Ferre M, Sarzi E, Bris C, et al. OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiology. Neurobiol Dis. 2016;90:20\u20136.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"1187_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ajo.2006.12.038","volume":"143","author":"AC Cohn","year":"2007","unstructured":"Cohn AC, Toomes C, Potter C, Towns KV, Hewitt AW, Inglehearn CF, et al. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. Am J Ophthalmol. 2007;143(4):656\u201362.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1187_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/79944","volume":"26","author":"C Alexander","year":"2000","unstructured":"Alexander C, Votruba M, Pesch UEA, Thiselton DL, Mayer S, Moore A, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26(2):211\u20135.","journal-title":"Nat Genet"},{"issue":"2","key":"1187_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/79936","volume":"26","author":"C Delettre","year":"2000","unstructured":"Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26(2):207\u201310.","journal-title":"Nat Genet"},{"issue":"6","key":"1187_CR10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/ana.20681","volume":"58","author":"P Amati-Bonneau","year":"2005","unstructured":"Amati-Bonneau P, Guichet A, Olichon A, Chevrollier A, Viala F, Miot S, et al. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol. 2005;58(6):958\u201363.","journal-title":"Ann Neurol"},{"issue":"6","key":"1187_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s00439-001-0633-y","volume":"109","author":"C Delettre","year":"2001","unstructured":"Delettre C, Griffoin JM, Kaplan J, Dollfus H, Lorenz B, Faivre L, et al. Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet. 2001;109(6):584\u201391.","journal-title":"Hum Genet"},{"issue":"2","key":"1187_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/mgme.2001.3278","volume":"75","author":"C Delettre","year":"2002","unstructured":"Delettre C, Lenaers G, Pelloquin L, Belenguer P, Hamel CP. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metab. 2002;75(2):97\u2013107.","journal-title":"Mol Genet Metab"},{"issue":"5\u20136","key":"1187_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.bbamcr.2006.04.003","volume":"1763","author":"A Olichon","year":"2006","unstructured":"Olichon A, Guillou E, Delettre C, Landes T, Arnaune-Pelloquin L, Emorine LJ, et al. Mitochondrial dynamics and disease, OPA1. Biochim Biophys Acta. 2006;1763(5\u20136):500\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20133","key":"1187_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0014-5793(02)02985-X","volume":"523","author":"A Olichon","year":"2002","unstructured":"Olichon A, Emorine LJ, Descoins E, Pelloquin L, Brichese L, Gas N, et al. The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett. 2002;523(1\u20133):171\u20136.","journal-title":"FEBS Lett"},{"issue":"6","key":"1187_CR15","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/S0002-9394(03)00665-2","volume":"136","author":"P Amati-Bonneau","year":"2003","unstructured":"Amati-Bonneau P, Odent S, Derrien C, Pasquier L, Malthiery Y, Reynier P, et al. The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene. Am J Ophthalmol. 2003;136(6):1170\u20131.","journal-title":"Am J Ophthalmol"},{"issue":"Pt 7","key":"1187_CR16","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1093\/brain\/aws340","volume":"136","author":"S Leruez","year":"2013","unstructured":"Leruez S, Milea D, Defoort-Dhellemmes S, Colin E, Crochet M, Procaccio V, et al. Sensorineural hearing loss in OPA1-linked disorders. Brain. 2013;136(Pt 7):e236.","journal-title":"Brain"},{"issue":"Pt 2","key":"1187_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/brain\/awm298","volume":"131","author":"P Amati-Bonneau","year":"2008","unstructured":"Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy \u2018plus\u2019 phenotypes. Brain. 2008;131(Pt 2):338\u201351.","journal-title":"Brain"},{"issue":"Pt 2","key":"1187_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/brain\/awm272","volume":"131","author":"G Hudson","year":"2008","unstructured":"Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain. 2008;131(Pt 2):329\u201337.","journal-title":"Brain"},{"issue":"1\u20132","key":"1187_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/13816818509007861","volume":"5","author":"F Meire","year":"1985","unstructured":"Meire F, De Laey JJ, de Bie S, van Staey M, Matton MT. Dominant optic nerve atrophy with progressive hearing loss and chronic progressive external ophthalmoplegia (CPEO). Ophthalmic Paediatr Genet. 1985;5(1\u20132):91\u20137.","journal-title":"Ophthalmic Paediatr Genet"},{"issue":"5","key":"1187_CR20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ajo.2004.06.011","volume":"138","author":"M Payne","year":"2004","unstructured":"Payne M, Yang Z, Katz BJ, Warner JE, Weight CJ, Zhao Y, et al. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1. Am J Ophthalmol. 2004;138(5):749\u201355.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1187_CR21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S0161-6420(84)34214-2","volume":"91","author":"RL Treft","year":"1984","unstructured":"Treft RL, Sanborn GE, Carey J, Swartz M, Crisp D, Wester DC, et al. Dominant optic atrophy, deafness, ptosis, ophthalmoplegia, dystaxia, and myopathy. A new syndrome. Ophthalmology. 1984;91(8):908\u201315.","journal-title":"Ophthalmology"},{"issue":"3","key":"1187_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0161-6420(80)35247-0","volume":"87","author":"CS Hoyt","year":"1980","unstructured":"Hoyt CS. Autosomal dominant optic atrophy. A spectrum of disability. Ophthalmology. 1980;87(3):245\u201351.","journal-title":"Ophthalmology"},{"issue":"Pt 3","key":"1187_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/awq007","volume":"133","author":"P Yu-Wai-Man","year":"2010","unstructured":"Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain. 2010;133(Pt 3):771\u201386.","journal-title":"Brain"},{"issue":"4","key":"1187_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ymgme.2011.04.018","volume":"103","author":"CP Schaaf","year":"2011","unstructured":"Schaaf CP, Blazo M, Lewis RA, Tonini RE, Takei H, Wang J, et al. Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations. Mol Genet Metab. 2011;103(4):383\u20137.","journal-title":"Mol Genet Metab"},{"issue":"Pt 10","key":"1187_CR25","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1093\/brain\/awu184","volume":"137","author":"D Bonneau","year":"2014","unstructured":"Bonneau D, Colin E, Oca F, Ferre M, Chevrollier A, Gueguen N, et al. Early-onset Behr syndrome due to compound heterozygous mutations in OPA1. Brain. 2014;137(Pt 10):e301.","journal-title":"Brain"},{"issue":"Pt 1","key":"1187_CR26","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1093\/brain\/awu234","volume":"138","author":"V Carelli","year":"2015","unstructured":"Carelli V, Sabatelli M, Carrozzo R, Rizza T, Schimpf S, Wissinger B, et al. \u2018Behr syndrome\u2019 with OPA1 compound heterozygote mutations. Brain. 2015;138(Pt 1):e321.","journal-title":"Brain"},{"key":"1187_CR27","first-page":"138","volume":"47","author":"C Behr","year":"1909","unstructured":"Behr C. Die komplizierte, hereditar-familiare Optikusatrophie des Kindesalters\u2013ein bisher nicht beschriebener Symptomkomplex. Klin Mbl Augenheilkd. 1909;47:138\u201360.","journal-title":"Klin Mbl Augenheilkd"},{"issue":"13 Pt 2","key":"1187_CR28","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1212\/01.wnl.0000289194.89359.a1","volume":"70","author":"C Verny","year":"2008","unstructured":"Verny C, Loiseau D, Scherer C, Lejeune P, Chevrollier A, Gueguen N, et al. Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy. Neurology. 2008;70(13 Pt 2):1152\u20133.","journal-title":"Neurology"},{"issue":"2","key":"1187_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jmedgenet-2015-103361","volume":"53","author":"R Spiegel","year":"2016","unstructured":"Spiegel R, Saada A, Flannery PJ, Burte F, Soiferman D, Khayat M, et al. Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation. J Med Genet. 2016;53(2):127\u201331.","journal-title":"J Med Genet"},{"issue":"5","key":"1187_CR30","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1212\/NXG.0000000000000188","volume":"3","author":"DS Lynch","year":"2017","unstructured":"Lynch DS, Loh SHY, Harley J, Noyce AJ, Martins LM, Wood NW, et al. Nonsyndromic Parkinson disease in a family with autosomal dominant optic atrophy due to OPA1 mutations. Neurol Genet. 2017;3(5):e188.","journal-title":"Neurol Genet"},{"issue":"1","key":"1187_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ana.24410","volume":"78","author":"V Carelli","year":"2015","unstructured":"Carelli V, Musumeci O, Caporali L, Zanna C, La Morgia C, Del Dotto V, et al. Syndromic parkinsonism and dementia associated with OPA1 missense mutations. Ann Neurol. 2015;78(1):21\u201338.","journal-title":"Ann Neurol"},{"issue":"13","key":"1187_CR32","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/hmg\/10.13.1359","volume":"10","author":"UE Pesch","year":"2001","unstructured":"Pesch UE, Leo-Kottler B, Mayer S, Jurklies B, Kellner U, Apfelstedt-Sylla E, et al. OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet. 2001;10(13):1359\u201368.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1187_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/humu.20161","volume":"25","author":"M Ferre","year":"2005","unstructured":"Ferre M, Amati-Bonneau P, Tourmen Y, Malthiery Y, Reynier P. eOPA1: an online database for OPA1 mutations. Hum Mutat. 2005;25(5):423\u20138.","journal-title":"Hum Mutat"},{"key":"1187_CR34","volume-title":"Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations","author":"M Ferre","year":"2009","unstructured":"Ferre M, Milea D, Chevrollier A, Verny C, Dollfus H, Ayuso C, et al. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Vienna: European Human Genetics Conference 2009; 2009. MAY 23-26, 2009"},{"issue":"1","key":"1187_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/humu.22703","volume":"36","author":"M Ferre","year":"2015","unstructured":"Ferre M, Caignard A, Milea D, Leruez S, Cassereau J, Chevrollier A, et al. Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data. Hum Mutat. 2015;36(1):20\u20135.","journal-title":"Hum Mutat"},{"issue":"7616","key":"1187_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285\u201391.","journal-title":"Nature"},{"issue":"1","key":"1187_CR37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308\u201311.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1187_CR38","doi-asserted-by":"publisher","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","volume":"45","author":"The UniProt C","year":"2017","unstructured":"The UniProt C. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2017;45(D1):D158\u2013D69.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"1187_CR39","first-page":"D36","volume":"41","author":"DA Benson","year":"2013","unstructured":"Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, et al. GenBank. Nucleic Acids Res. 2013;41(Database issue):D36\u201342.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"1187_CR40","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrg3932","volume":"16","author":"AJ Brookes","year":"2015","unstructured":"Brookes AJ, Robinson PN. Human genotype-phenotype databases: aims, challenges and opportunities. Nat Rev Genet. 2015;16(12):702\u201315.","journal-title":"Nat Rev Genet"},{"issue":"6","key":"1187_CR41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/humu.22986","volume":"37","author":"J Burn","year":"2016","unstructured":"Burn J, Watson M. The Human Variome project. Hum Mutat. 2016;37(6):505\u20137.","journal-title":"Hum Mutat"},{"key":"1187_CR42","doi-asserted-by":"crossref","unstructured":"Smith TD, Vihinen M, Human Variome P. Standard development at the Human Variome Project. Database (Oxford).2015;2015:bav024.","DOI":"10.1093\/database\/bav024"},{"issue":"D1","key":"1187_CR43","doi-asserted-by":"publisher","first-page":"D865","DOI":"10.1093\/nar\/gkw1039","volume":"45","author":"S Kohler","year":"2017","unstructured":"Kohler S, Vasilevsky NA, Engelstad M, Foster E, McMurry J, Ayme S, et al. The Human phenotype ontology in 2017. Nucleic Acids Res. 2017;45(D1):D865\u2013D76.","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"1187_CR44","doi-asserted-by":"publisher","first-page":"1700244","DOI":"10.1002\/pmic.201700244","volume":"17","author":"Y Perez-Riverol","year":"2017","unstructured":"Perez-Riverol Y, Ternent T, Koch M, Barsnes H, Vrousgou O, Jupp S, et al. Ols client and ols dialog: open source tools to annotate public omics datasets. Proteomics. 2017;17(19):1700244.","journal-title":"Proteomics"},{"issue":"1","key":"1187_CR45","doi-asserted-by":"publisher","first-page":"e1002033","DOI":"10.1371\/journal.pbio.1002033","volume":"13","author":"AR Deans","year":"2015","unstructured":"Deans AR, Lewis SE, Huala E, Anzaldo SS, Ashburner M, Balhoff JP, et al. Finding our way through phenotypes. PLoS Biol. 2015;13(1):e1002033.","journal-title":"PLoS Biol"},{"issue":"5","key":"1187_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/humu.22080","volume":"33","author":"PN Robinson","year":"2012","unstructured":"Robinson PN. Deep phenotyping for precision medicine. Hum Mutat. 2012;33(5):777\u201380.","journal-title":"Hum Mutat"},{"issue":"4","key":"1187_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ng0404-323","volume":"36","author":"LG Biesecker","year":"2004","unstructured":"Biesecker LG. Phenotype matters. Nat Genet. 2004;36(4):323\u20134.","journal-title":"Nat Genet"},{"issue":"Pt 1","key":"1187_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/brain\/awr323","volume":"135","author":"C Rouzier","year":"2012","unstructured":"Rouzier C, Bannwarth S, Chaussenot A, Chevrollier A, Verschueren A, Bonello-Palot N, et al. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy \u2018plus\u2019 phenotype. Brain. 2012;135(Pt 1):23\u201334.","journal-title":"Brain"},{"issue":"5","key":"1187_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/ng1341","volume":"36","author":"S Zuchner","year":"2004","unstructured":"Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-tooth neuropathy type 2A. Nat Genet. 2004;36(5):449\u201351.","journal-title":"Nat Genet"},{"issue":"12","key":"1187_CR50","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/jmedgenet-2014-102532","volume":"51","author":"MD Metodiev","year":"2014","unstructured":"Metodiev MD, Gerber S, Hubert L, Delahodde A, Chretien D, Gerard X, et al. Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause either isolated or syndromic optic neuropathy with encephalopathy and cerebellar atrophy. J Med Genet. 2014;51(12):834\u20138.","journal-title":"J Med Genet"},{"issue":"10","key":"1187_CR51","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1093\/brain\/awx219","volume":"140","author":"S Gerber","year":"2017","unstructured":"Gerber S, Charif M, Chevrollier A, Chaumette T, Angebault C, Kane MS, et al. Mutations in DNM1L, as in OPA1, result indominant optic atrophy despite opposite effectson mitochondrial fusion and fission. Brain. 2017;140(10):2586\u201396.","journal-title":"Brain"},{"issue":"5","key":"1187_CR52","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ajhg.2015.09.012","volume":"97","author":"C Angebault","year":"2015","unstructured":"Angebault C, Guichet PO, Talmat-Amar Y, Charif M, Gerber S, Fares-Taie L, et al. Recessive mutations in RTN4IP1 cause isolated and syndromic optic neuropathies. Am J Hum Genet. 2015;97(5):754\u201360.","journal-title":"Am J Hum Genet"},{"key":"1187_CR53","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fgene.2015.00311","volume":"6","author":"M Charif","year":"2015","unstructured":"Charif M, Roubertie A, Salime S, Mamouni S, Goizet C, Hamel CP, et al. A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability. Front Genet. 2015;6:311.","journal-title":"Front Genet"},{"issue":"Database issue","key":"1187_CR54","first-page":"D545","volume":"41","author":"KA Gray","year":"2013","unstructured":"Gray KA, Daugherty LC, Gordon SM, Seal RL, Wright MW, Bruford EA. Genenames.org: the HGNC resources in 2013. Nucleic Acids Res. 2013;41(Database issue):D545\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"1187_CR55","doi-asserted-by":"publisher","first-page":"D514","DOI":"10.1093\/nar\/gki033","volume":"33","author":"A Hamosh","year":"2005","unstructured":"Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33(Database issue):D514\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1187_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G","volume":"15","author":"A Hamosh","year":"2000","unstructured":"Hamosh A, Scott AF, Amberger J, Valle D, McKusick VA. Online Mendelian inheritance in Man (OMIM). Hum Mutat. 2000;15(1):57\u201361.","journal-title":"Hum Mutat"},{"issue":"6","key":"1187_CR57","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37(6):564\u20139.","journal-title":"Hum Mutat"},{"issue":"5","key":"1187_CR58","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/humu.21438","volume":"32","author":"IF Fokkema","year":"2011","unstructured":"Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011;32(5):557\u201363.","journal-title":"Hum Mutat"},{"issue":"2","key":"1187_CR59","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/humu.21646","volume":"33","author":"M Vihinen","year":"2012","unstructured":"Vihinen M, den Dunnen JT, Dalgleish R, Cotton RG. Guidelines for establishing locus specific databases. Hum Mutat. 2012;33(2):298\u2013305.","journal-title":"Hum Mutat"},{"issue":"5903","key":"1187_CR60","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.1167363","volume":"322","author":"RG Cotton","year":"2008","unstructured":"Cotton RG, Auerbach AD, Axton M, Barash CI, Berkovic SF, Brookes AJ, et al. GENETICS. The Human Variome Project. Science. 2008;322(5903):861\u20132.","journal-title":"Science"},{"issue":"Database issue","key":"1187_CR61","doi-asserted-by":"publisher","first-page":"D5","DOI":"10.1093\/nar\/gkp967","volume":"38","author":"EW Sayers","year":"2010","unstructured":"Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, Canese K, et al. Database resources of the National Center for biotechnology information. Nucleic Acids Res. 2010;38(Database issue):D5\u201316.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1187_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/humu.20654","volume":"29","author":"M Wildeman","year":"2008","unstructured":"Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PE. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat. 2008;29(1):6\u201313.","journal-title":"Hum Mutat"},{"issue":"6291","key":"1187_CR63","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1126\/science.aaf6162","volume":"352","author":"Global Alliance for Genomics and Health","year":"2016","unstructured":"Global Alliance for Genomics and Health. GENOMICS. A federated ecosystem for sharing genomic, clinical data. Science. 2016;352(6291):1278\u201380.","journal-title":"Science"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1187-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1187-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1187-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T09:04:17Z","timestamp":1599728657000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1187-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1187"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1187-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript is a retrospective case report that does not require the approval of the ethics committee by our institution; the database has been declared and anonymized in accordance with the ethical standards of our institution.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}